Faes Farma News
News
0
Ticker
FAE.MC
ISIN
ES0134950F36
Faes Farma Eulerpool News
Faes Farma Stock News
Faes Farma is being monitored by journalists and investors worldwide. We gather the latest Faes Farma news here.
Faes Farma Stock Press Releases
Faes Farma regularly publishes news on the company's website that are relevant for investors.
- February 25•Faes Farma
- February 25•Faes Farma
- February 15•Faes Farma
- November 26•Faes Farma
- October 29•Faes Farma
- September 21•Faes Farma
- July 28•Faes Farma
- April 30•Faes Farma
- April 12•Faes Farma
- March 9•Faes Farma
- February 26•Faes Farma
- January 15•Faes Farma
- January 4•Faes Farma
- October 29•Faes Farma
- July 29•Faes Farma
- June 30•Faes Farma
- April 30•Faes Farma
- February 28•Faes Farma
Faes Farma News 2026
This page contains all current news, analysis and press releases for Faes Farma stock (FAE.MC, ISIN: ES0134950F36). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at Faes Farma.
Faes Farma Stock
Faes Farma The history of Faes Farma SA dates back to 1933, when the company was founded in Barcelona, Spain. The founders had a vision to develop innovative products that would contribute to improving the health and well-being of people. Over the following decades, the company grew continuously and established itself as one of the leading players in the pharmaceutical industry. The business model of Faes Farma SA is focused on the development and marketing of products for the healthcare industry. The company relies on research and development to develop innovative solutions for various therapeutic areas. Faes Farma SA distributes its products worldwide through a network of partners and distributors, with a focus on Europe and Latin America. Faes Farma SA operates in three different divisions. The first division is pharmaceuticals, where the company offers products for various areas such as respiratory diseases, allergies, pain, and inflammation. An important part of this segment is the product Bilastine, which is used for the treatment of allergies and is considered an alternative to antihistamines. The second division is animal health. Here, Faes Farma SA offers products for the treatment of pets, including preparations against fleas, ticks, and worms. One of the most well-known products in this area is the Stangest brand, which is considered the leading brand for animal health in Spain. The third division of Faes Farma SA is the business of medical devices and diagnostics. Here, the company offers a wide range of products for various medical applications, including devices for monitoring vital signs and diagnostics for infectious diseases. Overall, Faes Farma SA is a company with a diversified product portfolio that is of interest to both end consumers and healthcare professionals and pet owners. The company has continuously developed and invested in research and development in recent years to expand its product offering and provide innovative solutions for various medical needs. Faes Farma SA is a company that stands out for its commitment to the development of innovative products and its dedication to the health and well-being of humans and animals. With a strong focus on research and development and a wide distribution network, the company has solidified its position in the pharmaceutical industry and will continue to play an important role in the market.